CB1 Capital will help 1933 analyze investments and partnerships
Inc () (OTCQX:TGIFF), the Vancouver cannabis cultivation and production company, has hired CB1 Capital Advisors LLC, a New York advisory firm, to serve as a strategic business adviser for a year.
As an advisory firm focused on cannabinoid-based wellness strategies, CB1 Capital will provide business development advice to 1933 that includes analyzing investments and partnerships.
READ: 1933 Industries steps up its CBD consumer product distribution in the US
“We have accumulated an equity position in and we look forward to working in an advisory capacity to assist the company in evaluating and pursuing business opportunities in the US,” said Todd Harrison, chief investment officer of CB1 Capital Management.
Operating via three subsidiaries, 1933 specializes in licensed medical and recreational cannabis cultivation and production as well as hemp-based and CBD-infused products and CBD extraction services.
The company owns 91% of both the Alternative Medicine Association and Infused MFG and 100% of Spire Global Strategy, a cannabis advisory firm.
READ: 1933 Industries stokes Las Vegas capacity expansion in anticipation of medical and recreational cannabis product demand
1933 shares added 10.2% to trade at $0.41 in New York in the morning trading session on Tuesday.
Contact Ellen Kelleher at [email protected]
CSE:TGIF
Market: CSE
Market Cap: $52.81 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of 1933 Industries Inc. named herein, including the promotion by the Company of 1933 Industries Inc. in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Buds & Duds: Cannabis shares start week mixed; 1933 Industries gains on new...
Cannabis stocks were mixed on Monday to open the trading week in North America. The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, stayed relatively flat, inching 0.2% higher to 170 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF...
on 09/23/2019
2 min read
Prev article
2 min read